NCT01609257 - Norovirus Bivalent-Vaccine Efficacy Study | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

July 16, 2012

Primary Completion Date

March 1, 2014

Study Completion Date

March 18, 2014

Conditions

Prevention From Norovirus Infection

Interventions

BIOLOGICAL

Norovirus Bivalent Vaccine

2 doses IM 28 days apart

BIOLOGICAL

Saline Comparator

2 doses IM 28 days apart

Trial Locations (5)

University of Rochester, Rochester

SNBL, Baltimore

Emory University, Atlanta

Cincinnati Childrens Hospital Medical Center, Cincinnati

Baylor College of Medicine, Houston